Drug Profile, Targeted by Tandem Mass Spectrometry and Enzyme Immunoassay, Urine
Also known as: PAIN HYB U
Use
This test provides a qualitative analysis to monitor medication compliance and detect undisclosed drug/substance use, supporting pain management, substance use disorders treatment, and other pharmacotherapies involving controlled substances. It is useful for identifying issues with drug absorption, timing of specimen collection, or noncompliance in patients under drug therapies.
Special Instructions
Not provided.
Limitations
This test does not distinguish between delta-8 and delta-9 forms of THC or their metabolites. Results may be affected by inappropriate timing of specimen collection, poor drug absorption, or diluted/adulterated urine. The presence of drugs is based on cutoff concentrations, and results that do not align with clinical expectations should be interpreted cautiously.
New York Approved
Methodology
Mass Spectrometry
Biomarkers
LOINC Codes
- 2161-8 - Creat Ur-mCnc
- 3507-1 - Codeine Ur Ql
- 3830-7 - Morphine Ur Ql
- 10976-9 - 6MAM Ur Ql
- 10998-3 - oxyCODONE Ur Ql
- 61424-8 - Noroxycodone Ur Ql Cfm
- 11247-4 - oxyMORphone Ur Ql
- 89302-4 - Noroxymorphone Ur Ql Scn
- 12308-3 - HYDROcodone Ur Ql
- 61421-4 - Norhydrocodone Ur Ql Cfm
- 9834-3 - HYDROmorphone Ur Ql
- 3414-0 - Buprenorphine Ur Ql
- 58362-5 - Norbuprenorphine Ur Ql Cfm
- 11235-9 - fentaNYL Ur Ql
- 43199-9 - Norfentanyl Ur Ql
- 58388-0 - Normeperidine Ur Ql Cfm
- 72485-6 - Tapentadol Ur Ql Scn
- 3773-9 - Methadone Ur Ql
- 43219-5 - traMADol Ur Ql
- 19343-3 - Amphet Ur Ql Scn
- 3779-6 - Methamphet Ur Ql
- 14267-9 - MDMA Ur Ql
- 42253-5 - MDA Ur Ql
- 61048-5 - MDEA Ur Ql
- 3957-8 - Phentermine Ur Ql
- 3393-6 - BZE Ur Ql
- 9351-8 - Alpraz Ur Ql
- 61036-0 - A-OH Alpraz Ur Ql
- 19245-0 - clonazePAM Ur Ql
- 61030-3 - 7Aminoclonazepam Ur Ql
- 3550-1 - diazePAM Ur Ql
- 3861-2 - Nordiazepam Ur Ql
- 12361-2 - Oxazepam Ur Ql
- 61060-0 - Temazepam Ur Ql
- 18187-5 - LORazepam Ur Ql
- 19585-9 - Midazolam Ur Ql Scn
- 33338-5 - Zolpidem Ur Ql
- 3377-9 - Barbiturates Ur Ql
- 55349-5 - Ethyl glucuronide Ur Ql
- 3435-5 - CarboxyTHC Ur Ql
- 3936-2 - PCP Ur Ql
- 21142-5 - Carisoprodol Ur Ql
- 11526-1 - Pathology study
- 3808-3 - Me-phenidate Ur Ql
- 94108-8 - 1OH-midazolam Ur Ql Scn
- 94103-9 - Zolpidem phenyl-4-carb Ur Ql Scn
- 92648-5 - Gabapentin Ur Ql Cfm
- 92649-3 - Naloxone Ur Ql Cfm
- 92651-9 - Pregabalin Ur Ql Cfm
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
4 mL
Minimum Volume
2 mL
Container
Two ARUP standard transport tubes of urine with no additives or preservatives
Causes for Rejection
Specimens exposed to repeated freeze/thaw cycles.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 1 week (Clonazepam may be unstable at ambient condition beyond three days) |
| Refrigerated | 1 month |
| Frozen | 1 month |
Other tests from different labs that may be relevant